ALB and neoplasm: The albumin-based nanocarrier PSN-HAS-PTX-IR780 showed enhanced drug delivery at the tumor site under mild temperature conditions, improved drug accumulation that enhanced therapeutic activity against the 4TI primary tumor and inhibited the metastasis by binding with metastasis-infiltrating platelets (platelet bridge) [111].